Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.50
+0.01000.67%
Post-market: 1.500.00000.00%19:27 EDT
Volume:178.38K
Turnover:251.04K
Market Cap:3.71M
PE:-0.08
High:1.53
Open:1.46
Low:1.32
Close:1.49
52wk High:17.68
52wk Low:1.29
Shares:2.47M
Float Shares:2.40M
Volume Ratio:0.65
T/O Rate:7.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.2914
EPS(LYR):-74.1816
ROE:-154.77%
ROA:-70.04%
PB:-0.72
PE(LYR):-0.02

Loading ...

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine

GlobeNewswire
·
Nov 21, 2025

60 Degrees Pharmaceuticals Faces Financial Challenges Amid Growth Efforts

TIPRANKS
·
Nov 18, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
Nov 17, 2025

60 Degrees Pharm Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Nov 14, 2025

60 Degrees Q3 EPS $(0.66) Beats $(1.21) Estimate, Sales $437.602K Beat $400.000K Estimate

Benzinga
·
Nov 14, 2025

60 Degrees Pharmaceuticals Q3 Operating Expenses USD 2.32 Million

THOMSON REUTERS
·
Nov 14, 2025

60 Degrees Pharmaceuticals Q3 Net Income USD -2.44 Million

THOMSON REUTERS
·
Nov 14, 2025

60 Degrees Pharmaceuticals Q3 EPS USD -0.66

THOMSON REUTERS
·
Nov 14, 2025

Press Release: 60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

Dow Jones
·
Nov 14, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees

Reuters
·
Oct 15, 2025

BUZZ-60 Degrees jumps after first patient in tick-borne illness trial clears infection

Reuters
·
Oct 15, 2025

60 Degrees Pharmaceuticals Inc - to Request Type B Meeting With FDA in Early 2026

THOMSON REUTERS
·
Oct 15, 2025

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

GlobeNewswire
·
Oct 15, 2025

60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting

TIPRANKS
·
Oct 11, 2025

60 Degrees Pharmaceuticals Inc held annual stockholders meeting

Reuters
·
Oct 11, 2025

60 Degrees Pharmaceuticals unveils name of chronic babesiosis trial

TIPRANKS
·
Oct 09, 2025

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-Free Chronic Babesiosis Study

THOMSON REUTERS
·
Oct 09, 2025